Calumet Specialty: Strong Fundamentals; Stock Buy (NASDAQ:CLMT)
Calumet's December results offer a view into the financial performance excluding MRL. Click here to read my thoughts on this update and why I consider CLMT a Buy.
Source: seekingalpha.com